| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 113.78% | Mizuho | $10 → $9 | Maintains | Buy |
| 09/25/2023 | -4.99% | Goldman Sachs | → $4 | Initiates Coverage On | → Sell |
| 09/22/2023 | 208.79% | Cantor Fitzgerald | → $13 | Initiates Coverage On | → Overweight |
| 08/11/2023 | 137.53% | Mizuho | $12 → $10 | Maintains | Buy |
| 08/08/2023 | 90.02% | Stifel | $10 → $8 | Maintains | Hold |
| 08/07/2023 | 137.53% | Morgan Stanley | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight |
| 08/04/2023 | 873.87% | HC Wainwright & Co. | → $41 | Reiterates | Buy → Buy |
| 05/05/2023 | 873.87% | HC Wainwright & Co. | → $41 | Reiterates | → Buy |
| 05/05/2023 | 185.04% | Barclays | $14 → $12 | Maintains | Overweight |
| 03/03/2023 | 137.53% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 03/02/2023 | 280.05% | BTIG | $54 → $16 | Maintains | Buy |
| 03/01/2023 | 185.04% | Citigroup | $17 → $12 | Maintains | Buy |
| 03/01/2023 | 873.87% | HC Wainwright & Co. | → $41 | Reiterates | → Buy |
| 01/24/2023 | 161.28% | Morgan Stanley | $13 → $11 | Maintains | Equal-Weight |
| 11/10/2022 | 303.8% | Citigroup | $19 → $17 | Maintains | Buy |
| 09/09/2022 | 208.79% | Morgan Stanley | $27 → $13 | Downgrades | Overweight → Equal-Weight |
| 07/11/2022 | 351.31% | Citigroup | $34 → $19 | Maintains | Buy |
| 07/07/2022 | 256.29% | Mizuho | → $15 | Initiates Coverage On | → Buy |
| 05/24/2022 | 42.52% | Goldman Sachs | $9 → $6 | Maintains | Sell |
| 05/11/2022 | 232.54% | Barclays | $42 → $14 | Maintains | Overweight |
| 04/13/2022 | 113.78% | Goldman Sachs | → $9 | Initiates Coverage On | → Sell |
| 03/08/2022 | 327.55% | Stifel | $32 → $18 | Downgrades | Buy → Hold |
| 02/25/2022 | 850.12% | Citigroup | $43 → $40 | Maintains | Buy |
| 09/27/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/03/2021 | 683.85% | Goldman Sachs | $29 → $33 | Maintains | Buy |
| 07/16/2021 | 1253.92% | Morgan Stanley | $33 → $57 | Maintains | Overweight |
| 04/19/2021 | 683.85% | Morgan Stanley | $31 → $33 | Maintains | Overweight |
| 01/15/2021 | 731.35% | B of A Securities | → $35 | Reinstates | → Buy |
| 07/29/2020 | 660.1% | Barclays | $36 → $32 | Maintains | Overweight |
| 06/24/2020 | 873.87% | HC Wainwright & Co. | → $41 | Initiates Coverage On | → Buy |
| 06/04/2020 | 636.34% | Morgan Stanley | $29 → $31 | Maintains | Overweight |
| 04/28/2020 | 660.1% | Goldman Sachs | → $32 | Initiates Coverage On | → Buy |
| 04/15/2020 | 588.84% | Morgan Stanley | $27 → $29 | Maintains | Overweight |
| 03/06/2020 | 850.12% | Citigroup | → $40 | Initiates Coverage On | → Buy |
| 02/19/2020 | 945.13% | Stifel | → $44 | Initiates Coverage On | → Buy |
| 11/21/2019 | 565.08% | BTIG | → $28 | Initiates Coverage On | → Buy |
| 03/04/2019 | — | Leerink Swann | Initiates Coverage On | → Outperform | |
| 03/04/2019 | — | B of A Securities | Initiates Coverage On | → Buy | |
| 03/04/2019 | 541.33% | Morgan Stanley | → $27 | Initiates Coverage On | → Overweight |
| 03/04/2019 | 541.33% | Barclays | → $27 | Initiates Coverage On | → Overweight |
What is the target price for Alector (ALEC)?
The latest price target for Alector (NASDAQ: ALEC) was reported by Mizuho on November 17, 2023. The analyst firm set a price target for $9.00 expecting ALEC to rise to within 12 months (a possible 113.78% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alector (ALEC)?
The latest analyst rating for Alector (NASDAQ: ALEC) was provided by Mizuho, and Alector maintained their buy rating.
When is the next analyst rating going to be posted or updated for Alector (ALEC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alector, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alector was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating Alector (ALEC) correct?
While ratings are subjective and will change, the latest Alector (ALEC) rating was a maintained with a price target of $10.00 to $9.00. The current price Alector (ALEC) is trading at is $4.21, which is out of the analyst's predicted range.